Potential abnormalities in molecular forms of growth hormone in schizophrenia: A pilot study

      This paper is only available as a PDF. To read, Please Download here.


      Growth hormone has been investigated in numerous studies involving patients with schizophrenia but has been measured only by radioimmunoassay (RIA). There have been no consistent abnormalities differentiating patients with schizophrenia from normal controls. In the current study, growth hormone (GH) variants were measured by Western blotting techniques, which resulted in the quantitation of 4 GH size variants: 27K (27,000 Daltons), 22K, 20K, and 17K. In the entire sample of 17 schizophrenic subjects, all GH variants were significantly higher than in the 14 normal controls. While there were no significant differences between the 2 groups in RIA GH values, the RIA values were generally higher in the schizophrenic group. In a subset of 12 schizophrenic patients whose RIA values were approximately equal to the controls, both the 27K and 22K GH variants remained significantly higher in the patient group. In the schizophrenic group, none of the GH variants or RIA GH changed significantly after 1 week of treatment with neuroleptic medication. These preliminary results suggest that certain GH forms may be elevated in schizophrenia, but further studies are needed.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Baumann G.
        Growth hormone heterogeneity: Genes, isohormones variants, and binding proteins.
        Endocr Rev. 1991; 12: 424-449
        • Lewis U.J.
        • Lewis L.J.
        • Salelm M.A.M.
        • Staten N.R.
        • Galosy S.S.
        • Krivi G.G.
        A recombinant-DNA-derived modification of human growth hormone (hGH 44-191) with enhanced diabetogenic activity.
        Molecular and Cellular Endocrinology. 1991; 78: 45-54
        • Lewis U.J.
        • Markoff E.
        • Culler F.L.
        • Hayek A.
        • VanderLaan W.P.
        Biological properties of the 20K-dalton variant of human growth hormone: A review.
        Endocr Japan. 1987; 34: 73-85
        • Mayerhoff D.I.
        • Lieberman J.A.
        • Lemus C.A.
        • Pollack S.
        • Schneider B.S.
        Growth hormone response to growth hormone-releasing hormone in schizophrenic patients.
        Am J Psychiatry. 1990; 147: 1072-1074
        • Meltzer H.Y.
        Neuroendocrine abnormalities in schizophrenia: Prolactin, growth hormone, and gonadotrophins.
        in: Brown G.M. Koslow S.H. Reichlin S. Neuroendocrinology in Psychiatric Disorder. Raven Press, New York1984: 1-28
        • Nerozzi D.
        • Magnani A.
        • Sforza V.
        • Scaramucci E.
        • Cerilli M.
        • Moretti C.
        • Antonozzi I.
        • Frajese G.
        Prolactin and growth hormone responses to growth hormone-releasing hormone in acute schizophrenia.
        Neuropsychobiology. 1990; 23: 15-17
        • Peabody C.A.
        • Warner M.D.
        • Markoff E.
        • Hoffman A.R.
        • Wilson D.M.
        • Csernansky J.G.
        Growth hormone response to growth hormone releasing hormone in depression and schizophrenia.
        Psychiatry Res. 1990; 33: 269-276
        • Sigel M.B.
        • VanderLaan W.P.
        • VanderLaan E.F.
        • Lewis U.J.
        Measurement of multiple forms of human growth hormone: Cross-reactivities in conventional and two-chain radioimmunassays.
        Endocrinology. 1980; 106: 92-97
        • Sinha Y.N.
        • Gilligan T.A.
        • Lee D.W.
        Detection of a high molecular weight variant of prolactin in human plasma by a combination of electrophoretic and immunologic techniques.
        J Clin Endocrinol Metab. 1984; 58: 752-754
        • Sinha Y.N.
        • Gilligan T.A.
        • Lee D.W.
        • Baxi S.C.
        • VanderLaan W.P.
        Demonstration of 20K GH in human plasma by gel electrophoretic-immunostaining-autoradiographic assay (GEISAA).
        Horm Metab Res. 1986; 18: 402-406
      1. Warner MD, Sinha YN, Peabody CA. Growth hormone and prolactin variants in normal subjects: relative proportions in morning and afternoon samples. Horm Metab Res (in press).